Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Anticancer Res ; 27(2): 1059-65, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17465244

RESUMEN

AIM: Maspin is a unique serine proteinase inhibitor which has tumor suppressor activity. The aim of the present study was to investigate the role of maspin in ampullary adenocarcinomas, its correlation with apoptosis and its value as a prognostic marker. PATIENTS AND METHODS: Twenty-three cases of ampulla of Vater adenocarcinoma were collected from archival material. For each sample, maspin, M30, p53 and Mib1 immunohistochemical reactivity were evaluated and results compared with clinicopathological parameters. RESULTS: A statistical relation was found between nuclear maspin and M30 (Spearman's Q = 0.46, p = 0.02), and p53 (Kruskal-Wallis = 0.03); a trend was found between nuclear maspin and pT (Kruskal-Wallis = 0.09), and pM (Mann-Whitney = 0.08) and pN status (Fisher's mid-point test: p = 0.070). CONCLUSION: The present study evaluated the role of maspin in ampullary adenocarcinomas and for the first time demonstrated its association with apoptosis, tumor growth and metastasis.


Asunto(s)
Adenocarcinoma/metabolismo , Ampolla Hepatopancreática/metabolismo , Ampolla Hepatopancreática/patología , Apoptosis/fisiología , Biomarcadores de Tumor/biosíntesis , Neoplasias del Conducto Colédoco/metabolismo , Serpinas/biosíntesis , Adenocarcinoma/patología , Adulto , Anciano , Anciano de 80 o más Años , Estudios de Cohortes , Neoplasias del Conducto Colédoco/patología , Femenino , Genes Supresores de Tumor , Humanos , Inmunohistoquímica , Antígeno Ki-67/biosíntesis , Masculino , Persona de Mediana Edad , Proteína p53 Supresora de Tumor/biosíntesis
2.
J Clin Pathol ; 60(3): 278-82, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-16644876

RESUMEN

AIMS: To report three cases of serous cystadenoma and endocrine tumour in the same pancreas, to review the literature and to evaluate the clinicopathological features of the tumours. CASES: Three women (71, 57 and 31 years old) were admitted to hospital, two for diseases unrelated to the pancreas and the third for increasing obstructive jaundice in von Hippel-Lindau disease. Preoperative examination showed two distinct lesions in the first patient and only cystic lesions in the other two. RESULTS: Histological examination of the pancreas showed one serous oligocystic adenoma associated with a benign, well-differentiated endocrine tumour, one serous oligocystic adenoma associated with an endocrine microadenoma, and a von Hippel-Lindau-related cystic neoplasm with a well-differentiated endocrine carcinoma. CONCLUSIONS: Serous cystadenoma associated with endocrine tumour shows some clinicopathological differences with respect to the two tumours considered separately, and with respect to von Hippel-Lindau-related cases, although there is no convincing evidence at present to justify considering this association as a separate entity.


Asunto(s)
Cistadenoma Seroso/patología , Neoplasias de las Glándulas Endocrinas/patología , Neoplasias Primarias Múltiples/patología , Neoplasias Pancreáticas/patología , Adulto , Anciano , Cistadenoma Seroso/metabolismo , Neoplasias de las Glándulas Endocrinas/metabolismo , Femenino , Humanos , Persona de Mediana Edad , Proteínas de Neoplasias/metabolismo , Neoplasias Primarias Múltiples/metabolismo , Neoplasias Pancreáticas/metabolismo , Enfermedad de von Hippel-Lindau/metabolismo , Enfermedad de von Hippel-Lindau/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...